Science 37 Website, Blog & Press Pages

Pricing Book Demo

Science 37 Website, Blog & Press Pages - aVenture

Science 37 - Library

Official pages and third-party coverage in one index.

science37.com21 items across 14 mapped pages · Crawled Sep 25, 2026

Official pages and third-party coverage in one index

Blog

7 pages

Breaking Through Mistrust to Better Mental Health in Black Communities/blog/breaking-through-mistrust-to-better-mental-health-in-black-communities
Reflecting upon Science 37’s “Mental Health & Clinical Trials in the Black Community” webinar (presented with George Floyd […]
Evolution or Revolution How Clinical Trial Recruitment Is Moving from Traditional Patient Referrals to Fully Consented Patient Enrollment/blog/evolution-or-revolution-how-clinical-trial-recruitment-is-moving-from-traditional-patient-referrals-to-fully-consented-patient-enrollment
How vital is clinical trial patient recruitment to the overall success of a clinical research […]
How Access to the Hpv Vaccination Is Helping to Eliminate Cervical Cancer/blog/how-access-to-the-hpv-vaccination-is-helping-to-eliminate-cervical-cancer
With the arrival of Cervical Health Awareness Month, comes news out of the U.K. that the human […]
Powering Rare Disease Research with Agile Decentralized and Patient Centric Approaches/blog/powering-rare-disease-research-with-agile-decentralized-and-patient-centric-approaches
The increased adoption of more agile, decentralized, and more patient-centric approaches is a very welcome […]

Careers & Hiring

1 page

Careers/careers
Explore jobs at Science 37 and help make clinical trials accessible worldwide. Build your career in research, nursing, or operations.

Comparison

1 page

Evolution or Revolution How Clinical Trial Recruitment Is Moving from Traditional Patient Referrals to Fully Consented Patient Enrollment/blog/evolution-or-revolution-how-clinical-trial-recruitment-is-moving-from-traditional-patient-referrals-to-fully-consented-patient-enrollment
How vital is clinical trial patient recruitment to the overall success of a clinical research […]

About

2 pages

About Us/about-us
Science 37 is the first FDA-inspected direct-to-patient clinical trial site, making research more accessible and accelerating breakthroughs through innovative, patient-focused solutions.
Partnerships/company/partnerships
Science 37 partners with CROs, biotechs, pharma, and advocacy groups to improve recruitment, retention, and trial access through its Direct-to-Patient Site direct-to-patient model.

Contact

1 page

Contact Us/contact-us
Have a question or need help at Science 37? Reach out via our contact form, call us at (984) 377-3737, or connect with the right team for personalized support

Homepage

1 page

Homepage/
Science 37 expands trial access, reaching a new and more diverse patient population. Deliver patient-friendly hybrid and decentralized clinical trials, with clinical research that works for everyone.,The Virtual Clinical Trial Direct-to-Patient Site—DCT and Hybrid Research

Privacy

1 page

Not yet classified

1 page

science37.com/
Science 37 expands trial access, reaching a new and more diverse patient population. Deliver patient-friendly hybrid and decentralized clinical trials, with clinical research that works for everyone.,The Virtual Clinical Trial Direct-to-Patient Site—DCT and Hybrid Research

Coverage

6 items

science37github.com/science37
GitHubRepository owner
Science 37 and Tufts CSDD Publish Landmark Study on Direct-to-Patient Site Performancescience37.com/science-37-and-tufts-csdd-publish-landmark-study-on-direct-to-patient-clinical-trial-site-performance-outperforming-industry-benchmarks/
Science 37 and Tufts CSDD publish a study on direct-to-patient clinical trial site performance. The research examines the direct-to-patient site model. It reports that the model enrolls 20% to 30% of study participants and has an 86% completion rate, outperforming industry benchmarks.
May 2026 · Science 37News article
Science 37 Completes Third FDA Inspection, Validating Quality of its Direct-to-Patient Sitescience37.com/science-37-completes-third-fda-inspection-validating-quality-of-its-direct-to-patient-site-in-pivotal-phase-3-rare-disease-trial/
Science 37 completes its third FDA inspection of its direct-to-patient site in a pivotal Phase 3 rare disease trial. The inspection receives a No Action Indicated categorization, with no Form 483 issued. The outcome validates the site's quality.
Oct 2025 · Science 37News article
Science 37 and Catalent Announce Partnership Enabling Universal Access to Clinical Researchscience37.com/science-37-and-catalent-announce-partnership-enabling-universal-access-to-clinical-research/
Science 37 and Catalent announce a strategic partnership for direct-to-patient delivery of investigational medicines. The collaboration supports enrollment of nearly 1,700 patients across 17 studies and more than 6,400 shipments. The companies say the model enables universal access to clinical research.
Sep 2025 · Science 37News article